Table 2.
Characteristics of all medication prescriptions in the study population
Women (n=1276) |
Men (n=1492) |
|
Medication group, n (%) | ||
ACEI/ARB | 619 (48.5) | 724 (48.5) |
Beta blocker | 571 (44.7) | 644 (43.2) |
MRA | 86 (6.7) | 124 (8.3) |
Target dose group, n (%) | ||
1%–49% | 564 (44.2) | 654 (43.8) |
50%–99% | 513 (40.2) | 608 (40.8) |
100% or higher | 199 (15.6) | 230 (15.4) |
Median target dose baseline prescriptions (IQR) | ||
ACEI/ARB | 50 (25.0–66.70) | 50 (25.00–57.10) |
Beta blocker | 25 (25.00–50.00) | 25 (25.00–50.00) |
MRA | 50 (50.00–50.00) | 50 (50.00–50.00) |
ACEI, ACE inhibitor; ARB, angiotensin-receptor blocker; MRA, mineralocorticoid receptor antagonist.